Final answer:
The dosage of Sotalol IV for antiarrhythmic infusion in the treatment of stable wide-QRS tachycardia should be determined by a healthcare professional based on the patient's specific condition, with a focus on individualized patient care and safety.
Step-by-step explanation:
The treatment for stable wide-QRS tachycardia may involve the administration of antiarrhythmic drugs, including Sotalol, which is a medication that can be delivered via intravenous (IV) infusion. Sotalol is part of the beta blockers group but also has antiarrhythmic properties. When used in a medical setting, especially for arrhythmias, the specific dosing regimen should be determined by a healthcare professional based on the individual patient's condition. Patients who experience more severe symptoms of an arrhythmia may require urgent procedures like cardioversion or defibrillation. For those undergoing open-heart surgery, potassium chloride (KCl) may be used to stop the heart as mentioned in the context of cardiac surgery.
Since the dosage of Sotalol IV for antiarrhythmic infusion must be tailored to the patient's needs, generally following guidelines such as those provided by clinical protocols or drug manufacturers, it's imperative that dosing is managed by healthcare providers.